» Authors » Timothy L Wiemken

Timothy L Wiemken

Explore the profile of Timothy L Wiemken including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 89
Citations 1091
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Keane A, Tippett A, Taylor E, Reese O, Salazar L, De Castro K, et al.
Vaccines (Basel) . 2024 Jun; 12(6). PMID: 38932386
It is important to understand real-world BNT162b2 COVID-19 vaccine effectiveness (VE), especially among racial and ethnic minority groups. We performed a test-negative case-control study to measure BNT162b2 COVID-19 VE in...
2.
Andersen K, Khan F, Park P, Wiemken T, Emir B, Malhotra D, et al.
PLoS One . 2024 Apr; 19(4):e0300570. PMID: 38578822
Objective: To create a data-driven definition of post-COVID conditions (PCC) by directly measure changes in symptomatology before and after a first COVID episode. Materials And Methods: Retrospective cohort study using...
3.
Wiemken T, Carrico R
Am J Infect Control . 2024 Mar; 52(6):625-629. PMID: 38483430
Background: Health care-associated infection (HAI) surveillance is vital for safety in health care settings. It helps identify infection risk factors, enhancing patient safety and quality improvement. However, HAI surveillance is...
4.
Appaneal H, LaPlante K, Lopes V, Martin C, Puzniak L, Wiemken T, et al.
Infect Dis Ther . 2024 Jan; 13(1):155-172. PMID: 38217842
Introduction: Limited data exist regarding real-world utilization of nirmatrelvir/ritonavir. We identified predictors of nirmatrelvir/ritonavir use among Veterans Affairs (VA) outpatients nationally. Methods: We conducted a retrospective cohort study among outpatients...
5.
Rudolph A, Khan F, Shah A, Singh T, Wiemken T, Puzniak L, et al.
J Infect Dis . 2023 Nov; 229(3):648-659. PMID: 37925630
Background: Data on the effectiveness of BA.4/5 bivalent vaccine stratified by age and prior infection are lacking. Methods: This test-negative study used data from individuals ≥5 years of age testing...
6.
Di Fusco M, Marczell K, Thoburn E, Wiemken T, Yang J, Yarnoff B
J Med Econ . 2023 Mar; 26(1):509-524. PMID: 36942976
Objective: To assess the public health impact and economic value of booster vaccination with the Pfizer-BioNTech COVID-19 Vaccine, Bivalent in the United States. Methods: A combined cohort Markov decision tree...
7.
Wiemken T, Khan F, Puzniak L, Yang W, Simmering J, Polgreen P, et al.
Sci Rep . 2023 Mar; 13(1):3886. PMID: 36890264
Determining whether SARS-CoV-2 exhibits seasonality like other respiratory viruses is critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal pattern using time series models. We used...
8.
Welch V, Metcalf T, Macey R, Markus K, Sears A, Enstone A, et al.
Vaccines (Basel) . 2023 Jan; 11(1). PMID: 36680024
Influenza is a common respiratory infection associated with a substantial clinical, humanistic, and economic burden globally. Vaccines are essential to prevent and control influenza and are recommended by public-health agencies,...
9.
Khan F, Nguyen J, Singh T, Puzniak L, Wiemken T, Schrecker J, et al.
JAMA Netw Open . 2022 Dec; 5(12):e2246915. PMID: 36515946
Importance: Data describing the vaccine effectiveness (VE) and durability of BNT162b2 among children 5 to 11 years of age are needed. Objective: To estimate BNT162b2 VE against SARS-CoV-2 infection among...
10.
Clarke J, Wiemken T, Korenblat K
Transplantation . 2022 Aug; 106(12):2399-2407. PMID: 36042551
Background: The COVID-19 pandemic is the first sustained respiratory disease pandemic to arise since the start of solid organ transplantation (SOT). Prior studies have demonstrated that SOT recipients are at...